HHS Finds 885 Drugs Misclassified Under Medicaid, $1.3 Billion in Missing Rebates

Drug Industry Daily
An HHS audit of the Medicaid drug rebate program found hundreds of misclassifications by manufacturers — which may have led to more than $1.3 billion in lost rebates payable to the federal government over the past five years.

To View This Article:


Subscribe To Drug Industry Daily